Canadian Imperial Ginseng Products Ltd. – Trademark Portfolio

Entity Type: 03

Canadian Imperial Ginseng Products Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. The owner is based in Vancouver, B.C. V6C 3C8.

23rd Floor

885 West Georgia Street

Vancouver, B.C. V6C 3C8 , CA

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Canadian Imperial Ginseng Products Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

31
Natural Agricultural Products (3 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (3 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Canadian Imperial Ginseng Products Ltd. have?

Canadian Imperial Ginseng Products Ltd. has 3 U.S. trademarks filed with the USPTO.

What trademark classes does Canadian Imperial Ginseng Products Ltd. file in?

Canadian Imperial Ginseng Products Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.

What is Canadian Imperial Ginseng Products Ltd.'s trademark registration success rate?

Canadian Imperial Ginseng Products Ltd. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.